clindamycin has been researched along with Kawasaki Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farley, LF; Hodo, LN | 1 |
| Arlaud, K; Bosdure, E; Bosland, A; Dubus, JC; Fouilloux, V; Paut, O; Rousset-Rouvière, C | 1 |
| Chan, L; Chinnock, B | 1 |
3 other study(ies) available for clindamycin and Kawasaki Disease
| Article | Year |
|---|---|
An 8-year-old male with 4 days of fever, abdominal pain, and jaundice.
Topics: Abdominal Pain; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Cardiomyopathy, Dilated; Ceftriaxone; Child; Clindamycin; Conjunctivitis; Diagnosis, Differential; Fever; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infliximab; Jaundice; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Nafcillin; Shock, Septic; Sodium Chloride; Treatment Outcome | 2014 |
[Streptococcal toxic shock syndrome or Kawasaki disease? Two case studies of children with group A streptococcal pneumonia empyema].
Topics: Anti-Bacterial Agents; Child, Preschool; Clindamycin; Diagnosis, Differential; Drug Therapy, Combination; Empyema, Pleural; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Male; Mucocutaneous Lymph Node Syndrome; Pneumonia, Pneumococcal; Shock, Septic; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome | 2011 |
Clinicopathological conference: multisystem failure in a child.
Topics: Anti-Bacterial Agents; Aspirin; Child; Clindamycin; Female; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Syndrome; Multiple Organ Failure; Shock, Septic; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome | 2000 |